Elite Pharma Stock Price (OTCBB:ELTP)

Add to My Stocks
$0.09 $0 (0%) ELTP stock closing price Sep 18, 2018 (Closing)
Prev Close* : $0.09
Market Cap:
$74.82M
Day Low: $0.09
52 Week Low: $0.06
Open: $0.09
Volume: -
Day High: $0.1
52 Week High: $0.15
Dividend:
0.00

Latest Stock Market News

Latest Articles

ELTP Stockcharts

View ELTP PE ratio, PS ratio stocks charts and compare with peers.
ELTP Chart
Note: Compare Elite Pharma stock price history with the index and industry peers.

Elite Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
9.42
PB ratio (
price to book ratio
)
15.82

Elite Pharma Returns

ROE
(return on equity)
-68%

Elite Pharma Financial Ratios

Asset Turnover
0.29
Receivables Turnover
8.45
Debt to Equity
1.3
Dividend Yield
0%

ELTP Industry Peers

Company Price Change (%)
Otonomy (OTIC)2.60.05 (1.89%)
Kempharma (KMPH)4.980.13 (2.68%)
Zogenix (ZGNX)48.650.15 (0.31%)
Durect (DRRX)1.130.02 (1.8%)
Nektar Therapeutics (NKTR)58.330.02 (0.03%)
Albany Molecular Research (AMRI)21.740 (0%)
Acura Pharma (ACUR)0.160.03 (23.08%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

Elite Pharma Financial Statements

income statement20182017201620152014
Net Sales or Revenues7.45M9.63M12.49M5.01M4.6M
Net Income-3.67M3.81M-0.68M28.92M-96.57M
Total Operating Expense12.19M10.74M15.65M17.88M6.13M
View Elite Pharma income statement
balance sheet20182017201620152014
Total Assets30.88M34.31M31.87M25.92M24.31M
Total Liabilities26.31M8.64M65M60.65M105.51M
Shareholders Equity4.57M25.66M-33.12M-34.73M-81.19M
View Elite Pharma balance sheet
cash flow statement20182017201620152014
Net Increase (Decrease) in Assets Liabilities--4.55M1.87M-0.16M-
Net Cash from (used by) Operating Activities-4.8M-7.88M-2.76M-15.1M-4.21M
Increase (Decrease) in Prop Plant And Equipment-0.18M-1.09M-1.91M3.03M-0.5M
View Elite Pharma cash flow statement

Elite Pharma Stock Message Board

Elite Pharma stock lost 0%, and the last close price as of Sep 18, 2018 is $0.09 for ELTP stock. Elite Pharma market capitalization is $74.82M and it represents the total market value of ELTP stock. A value investor must look at the fundamentals of a stock, and perform Elite Pharma valuation, even though in the short-term, sentiment and current breaking news might affect Elite Pharma stock price.

For recognizing and analyzing the real performance of Elite Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in Elite Pharma stock quote data shows the number of shares traded. For Ex: 569,755 Elite Pharma shares were traded as of last trading day, as seen from Elite Pharma stock chart. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Elite Pharma does not pay dividends. To check the historical stock price movement, all time high, and all time low of ELTP, view Elite Pharma stock price history.